Cordant Inc’s West Pharmaceutical WST Stock Holding History

Cordant Inc’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14	Closed	-$6K	–	1268
2022 Q1	$6K	Buy	+14	New	+$5.48K	﹤0.01%	234
2020 Q1	–	Sell	-40	Closed	-$6K	–	198
2019 Q4	$6K	Buy	+40	New	+$5.82K	0.01%	114

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Cordant Inc's WST Position: Q2 2022 in Review

Cordant Inc sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 14 shares — an estimated $6K sold.

Cordant Inc first reported a position in WST in Q4 2019 and held it in 2 quarters. The position peaked at $6K in Q1 2022. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

Cordant Inc reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 14 West Pharmaceutical shares in Q2 2022, an estimated $6K.
Cordant Inc first reported a position in West Pharmaceutical in Q4 2019 and held it in 2 quarters.
Cordant Inc's West Pharmaceutical position peaked at $6K in Q1 2022.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.